📝 Gayatri BioOrganics Ltd — results explained
Quarter ended March 2026 (Q4 FY26)
Gayatri BioOrganics Ltd reported revenue of ₹0 crore for the quarter ended March 2026 (Q4 FY26).
The company reported a net loss of ₹0 crore, against a net loss of ₹0 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.05.
Full year and trailing twelve months
For the full year FY26, Gayatri BioOrganics Ltd posted revenue of ₹0 crore, with a net loss of ₹1 crore.
On a trailing-twelve-month (TTM) basis, revenue stands at ₹0 crore with a net loss of ₹1 crore.
Valuation snapshot
At the current price of ₹7.49, 524564 has a market capitalisation of ₹63 crore.
Within the Commodity Chemicals industry, it is the 22nd-largest of the 50 companies we track by market value.
Shareholding pattern
As of Mar 2026, promoters held 21.59%, foreign institutional investors (FIIs) 0.01%, domestic institutional investors (DIIs) 0.65%, public shareholders 77.75% of Gayatri BioOrganics Ltd.